The Life History of 21 Breast Cancers

Nik-Zainal, Serena, Van Loo, Peter, Wedge, David C., Alexandrov, Ludmil B., Greenman, Christopher D., Lau, King Wai, Raine, Keiran, Jones, David +41 more·2012·Cell
DOI 10.1016/j.cell.2012.04.023

Cited by (1,000)

Items 501–600 of 1,000

  1. Repair of base damage within break-induced replication intermediates promotes kataegis associated with chromosome rearrangements
    Rajula Elango, Beth Osia, Victoria Harcy, Ewa P. Malc, Piotr A. Mieczkowski, Steven A. Roberts, Anna Malkova · 2019 · Nucleic Acids Research
  2. Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease
    Avgi Andreou, Bryndís Yngvadóttir, Laia Bassaganyas, Graeme R. Clark, Jose‐Ezequiel Martín, James Whitworth, Alex J. Cornish, Richard S. Houlston, Philip M. Rich, Catherine A. Egan et al. · 2022 · Human Molecular Genetics
  3. Phenotypic noise and plasticity in cancer evolution
    Frederick J.H. Whiting, Jacob Househam, Ann‐Marie Baker, Andrea Sottoriva, Trevor A. Graham · 2023 · Trends in Cell Biology
  4. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinomain situ
    Hitchintan Kaur, Shihong Mao, Seema K. Shah, David H. Gorski, Stephen A. Krawetz, Bonnie F. Sloane, Raymond R. Mattingly · 2013 · Expert Review of Molecular Diagnostics
  5. MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations
    Xing Hua, Paula L. Hyland, Jing Li Huang, Lei Song, Bin Zhu, Neil E. Caporaso, Maria Teresa Landi, Nilanjan Chatterjee, Jianxin Shi · 2016 · The American Journal of Human Genetics
  6. Personalized genomic disease risk of volunteers
    Manuel L. Gonzalez‐Garay, Amy L. McGuire, Stacey Pereira, C. Thomas Caskey · 2013 · Proceedings of the National Academy of Sciences
  7. The origins of breast cancer associated with mammographic density: a testable biological hypothesis
    Norman F. Boyd, Hal K. Berman, Jie Zhu, Lisa J Martin, Martin J. Yaffe, Sofia Chavez, Greg J. Stanisz, Greg Hislop, Anna Maria Chiarelli, Salomon Minkin et al. · 2018 · Breast Cancer Research
  8. Lineage Tracing: Computational Reconstruction Goes Beyond the Limit of Imaging.
    Szu-Hsien Sam Wu, Ji‐Hyun Lee, Bon‐Kyoung Koo · 2019 · Europe PMC (PubMed Central)
  9. Genome management and mismanagement—cell-level opportunities and challenges of whole-genome duplication
    Levi J Yant, Kirsten Bomblies · 2015 · Genes & Development
  10. Single-cell copy number calling and event history reconstruction
    Jack Kuipers, Mustafa Anıl Tuncel, Pedro Ferreira, Katharina Jahn, Niko Beerenwinkel · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Mitochondrial DNA mosaicism in normal human somatic cells
    Jisong An, Chang Hyun Nam, Ryul Kim, Yunah Lee, Hyein Won, Seongyeol Park, Won Hee Lee, Hansol Park, Sung-Soo Yoon, Yohan An et al. · 2024 · Nature Genetics
  12. The APOBEC3 genes and their role in cancer: insights from human papillomavirus
    Nicola Jane Smith, Tim R. Fenton · 2019 · Journal of Molecular Endocrinology
  13. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
    Yulia Rubanova, Ruian Shi, Caitlin F. Harrigan, Roujia Li, Jeff A. Wintersinger, Nil Sahin, Amit G. Deshwar, PCAWG Evolution and Heterogeneity Working Group, Stefan C. Dentro, Ignaty Leshchiner et al. · 2020 · Nature Communications
  14. Whole-Genome Sequencing of Asian Lung Cancers: Second-Hand Smoke Unlikely to Be Responsible for Higher Incidence of Lung Cancer among Asian Never-Smokers
    Vidhya Gomathi Krishnan, Philip J. Ebert, Jason C. Ting, Elaine Hsuen Lim, Swee Seong Wong, Audrey S.M. Teo, Yong Gang Yue, Hui-Hoon Chua, Xiwen Ma, Gary S.L. Loh et al. · 2014 · Cancer Research
  15. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
    Benjamin T. Diamond, Bachisio Ziccheddu, Kylee H. Maclachlan, Justin Taylor, Eileen Mary Boyle, Juan Arango Ossa, Jacob Jahn, Maurizio Affer, Tulasigeri M. Totiger, David Glen Coffey et al. · 2023 · Blood
  16. Adapting Clinical Paradigms to the Challenges of Cancer Clonal Evolution
    Nirupa Murugaesu, Su Kit Chew, Charles Swanton · 2013 · American Journal Of Pathology
  17. Bias from removing read duplication in ultra-deep sequencing experiments
    Wanding Zhou, Tenghui Chen, Hao Zhao, Agda Karina Eterovic, Funda Meric‐Bernstam, Gordon Brent Mills, Ken Chen · 2014 · Bioinformatics
  18. Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 Levels
    Matteo D’Antonio, Pablo Tamayo, Jill P. Mesirov, Kelly A. Frazer · 2016 · Cell Reports
  19. Natural and chemotherapy-induced clonal evolution of tumors
    Marina Konstantinovna Ibragimova, Matvey Mikhailovich Tsyganov, Николай Васильевич Литвяков · 2017 · Biochemistry (Moscow)
  20. The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer
    Peter A. Barry, Alexandra I. Vatsiou, Inmaculada Spiteri, Daniel Nichol, George D. Cresswell, Ahmet Acar, Nicholas Trahearn, Sarah Hrebien, Isaac García-Murillas, Kate Chkhaidze et al. · 2018 · Clinical Cancer Research
  21. Development, maturation, and maintenance of human prostate inferred from somatic mutations
    Sebastian Großmann, Yvette E. Hooks, Laura Wilson, Luiza Moore, Laura O’Neill, Iñigo Martincorena, Thierry Voet, Michael R. Stratton, Rakesh Heer, Peter J. Campbell · 2021 · Cell stem cell
  22. Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
    Xu, Jianing, Reznik, Ed, Lee, Ho-Joon, Gundem, Gunes, Jonsson, Philip, Sarungbam, Judy, Bialik, Anna, Sanchez-Vega, Francisco, Creighton, Chad J, Hoekstra, Jake et al. · 2019 · eLife
  23. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
    Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, Stefano Cagnin · 2023 · Journal of Experimental & Clinical Cancer Research
  24. Molecular tests as prognostic factors in breast cancer
    Marc J. van de Vijver · 2014 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  25. Learning Oncogenetic Networks by Reducing to Mixed Integer Linear Programming
    Hossein Farahani, Jens Lagergren · 2013 · PLoS ONE
  26. Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer
    Adam Shlien, Keiran M. Raine, Fabio Fuligni, Roland R. Arnold, Serena Nik‐Zainal, Serge Dronov, Lira Mamanova, Andrej Rosic, Young Seok Ju, Susanna L. Cooke et al. · 2016 · Cell Reports
  27. CONET: copy number event tree model of evolutionary tumor history for single-cell data
    Magda Markowska, Tomasz Cąkała, Błażej Miasojedow, Bogac Aybey, Dilafruz Juraeva, Johanna Mazur, Edith M. Ross, Eike Staub, Ewa Szczurek · 2022 · Genome biology
  28. Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma
    Naser Ansari‐Pour, Mehmet Samur, Erin Flynt, Sarah Gooding, Fadi Towfic, Nicholas Stong, María Ortiz Estévez, Konstantinos Mavrommatis, Brian A. Walker, Gareth John Morgan et al. · 2022 · Blood
  29. Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
    Elza C. de Bruin, Tiffany Taylor, Charles Swanton · 2013 · Genome Medicine
  30. The Evolutionarily Stable Distribution of Fitness Effects
    Daniel P. Rice, Benjamin H. Good, Michael M. Desai · 2015 · Genetics
  31. Proteogenomic convergence for understanding cancer pathways and networks
    Emily S. Boja, Henry Rodriguez · 2014 · Clinical Proteomics
  32. Activation-induced deoxycytidine deaminase (AID) co-transcriptional scanning at single-molecule resolution
    Gayan Senavirathne, Jeffrey G. Bertram, Malgorzata M. Jaszczur, Kathy R. Chaurasiya, Phuong Pham, Chi H. Mak, Myron F. Goodman, David Rueda · 2015 · Nature Communications
  33. Turning Hepatic Cancer Stem Cells Inside Out – A Deeper Understanding through Multiple Perspectives
    Lok-Hei Chan, Steve Tin-Chi Luk, Stephanie Ma · 2015 · Molecules and Cells
  34. A phylogenetic latent feature model for clonal deconvolution
    Francesco Marass, Florent C. Mouliere, Ke Yuan, Nitzan Rosenfeld, Florian M. Markowetz · 2016 · The Annals of Applied Statistics
  35. Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking
    George D. Cresswell, Daniel Nichol, Inmaculada Spiteri, Haider Tari, Luis Zapata, Timon Heide, Carlo C. Maley, Luca Magnani, Gaia Schiavon, Alan Ashworth et al. · 2020 · Nature Communications
  36. Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants
    Yukiko Inagaki‐Kawata, Kenichi Yoshida, Nobuko Kawaguchi‐Sakita, Masahiro Kawashima, Tomomi Nishimura, Noriko Senda, Yusuke Shiozawa, Yasuhide Takeuchi, Yoshikage Inoue, Aiko Sato‐Otsubo et al. · 2020 · Communications Biology
  37. Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
    Emily Kanaya Slotkin, Anita S. Bowman, Max Fine Levine, Filemon S. Dela Cruz, Diego F. Coutinho, Glorymar D. Ibanez Sanchez, Néstor Rosales, Shakeel I. Modak, William D. Tap, Mrinal M. Gounder et al. · 2021 · Molecular Cancer Research
  38. Breast Cancer Heterogeneity in Primary and Metastatic Disease
    Lauren Kalinowski, Jodi M. Saunus, Amy E. McCart Reed, Sunil R. Lakhani · 2019 · Advances in experimental medicine and biology
  39. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours
    Luwei Tao, Dongxi Xiang, Ying Xie, Roderick Terry Bronson, Zhe Li · 2017 · Nature Communications
  40. Experimental Evolution of Extreme Resistance to Ionizing Radiation in Escherichia coli after 50 Cycles of Selection
    Steven T. Bruckbauer, Joseph D. Trimarco, Joel Martin, Brian Bushnell, Katherine A Senn, Wendy Schackwitz, Anna Lipzen, Matthew J. Blow, Elizabeth A. Wood, Wesley S. Culberson et al. · 2019 · Journal of Bacteriology
  41. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches
    Dohoon Lee, Youngjun Park, Sun Kim · 2020 · Briefings in Bioinformatics
  42. MPL resolves genetic linkage in fitness inference from complex evolutionary histories
    Muhammad Saqib Sohail, Raymond H. Y. Louie, Matthew R. McKay, John P. Barton · 2020 · Nature Biotechnology
  43. Maskless fabrication of cell-laden microfluidic chips with localized surface functionalization for the co-culture of cancer cells
    Qudus Hamid, Chengyang Wang, Jessica Snyder, Shannon Williams, Yigong Liu, Wei Sun · 2015 · Biofabrication
  44. Multi-omic cross-sectional cohort study of pre-malignant Barrett’s esophagus reveals early structural variation and retrotransposon activity
    Annalise Katz‐Summercorn, Sriganesh Jammula, Anna Frangou, Iliana Peneva, M. O’Donovan, Monika Tripathi, Shalini Malhotra, Massimiliano di Pietro, Sujath Abbas, Ginny Devonshire et al. · 2022 · Nature Communications
  45. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
    Changshu Li, Jun Shao, Peiyi Li, Jiaming Feng, Jingwei Li, Chengdi Wang · 2023 · Cancer Letters
  46. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction
    Kristiana Grigoriadis, Ariana Huebner, Abigail Bunkum, Emma Colliver, Alexander M. Frankell, Mark S. Hill, Kerstin Thol, Nicolai J. Birkbak, Charles Swanton, Simone Zaccaria et al. · 2023 · Nature Protocols
  47. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition
    Mohamed Jèmaà, Gwenola Manic, Gwendaline Lledo, Delphine Lissa, Christelle Reynès, Nathalie Morin, Frédéric Chibon, Antonella Sistigu, Maria Castedo, Ilio Vitale et al. · 2015 · Oncotarget
  48. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing
    Guoli Li, Xinwu Guo, Lili Tang, Ming Chen, Xipeng Luo, Limin Peng, Xunxun Xu, Shouman Wang, Zhi Qiang Xiao, Wenjun Yi et al. · 2017 · Journal of Cancer Research and Clinical Oncology
  49. A phylogenetic latent feature model for clonal deconvolution
    Francesco Marass, Florent C. Mouliere, Ke Yuan, Nitzan Rosenfeld, Florian M. Markowetz · 2016 · Apollo (University of Cambridge)
  50. Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
    Yin Wu, Dhruva Biswas, Charles Swanton · 2021 · Seminars in Cancer Biology
  51. Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis
    Xueqi Yan, Yinghong Xie, Fan Yang, Yijia Hua, Tianyu Zeng, Chunxiao Sun, Mengzhu Yang, Xiang Huang, Hao Wu, Ziyi Fu et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  52. Uphyloplot2: visualizing phylogenetic trees from single-cell RNA-seq data
    Stefan Kurtenbach, Anthony M. Cruz, Daniel A. Rodriguez, Michael A. Durante, J. William Harbour · 2021 · BMC Genomics
  53. Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution
    Kerstin Thol, Piotr Pawlik, Nicholas McGranahan · 2022 · Genome Medicine
  54. Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics
    Byoungkoo Lee, Jessica Marie Konen, Scott C. Wilkinson, Adam I. Marcus, Yi Jiang · 2017 · Scientific Reports
  55. Genetic and epigenetic basis of chronic lymphocytic leukemia
    José Ignacio Martín-Subero, Carlos López-Otı́n, Elı́as Campo · 2013 · Current Opinion in Hematology
  56. Precision Medicine in Breast Cancer: Genes, Genomes, and the Future of Genomically Driven Treatments
    Daniel G. Stover, Nikhil Wagle · 2015 · Current Oncology Reports
  57. Inferring the paths of somatic evolution in cancer
    Navodit Misra, Ewa Szczurek, Martin Vingron · 2014 · Bioinformatics
  58. The clonal relationships between pre‐cancer and cancer revealed by ultra‐deep sequencing
    Henry M. Wood, Caroline Conway, Catherine L. Daly, Rebecca Chalkley, Stefano Berri, Burcu Şengüven, Lucy F. Stead, Lisa Ross, Philip Anthony Egan, Preetha Chengot et al. · 2015 · The Journal of Pathology
  59. Modeling the Subclonal Evolution of Cancer Cell Populations
    Diego Chowell, James Napier, Rohan V. Gupta, Karen S. Anderson, Carlo C. Maley, Melissa A. Wilson Sayres · 2017 · Cancer Research
  60. Computational approaches for inferring tumor evolution from single-cell genomic data
    Hamim Zafar, Nicholas E. Navin, Luay K. Nakhleh, Ken Chen · 2017 · Current Opinion in Systems Biology
  61. Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
    Roy Rabbie, Naser Ansari‐Pour, Oliver M. Cast, Doreen Lau, Francis Scott, Sarah Joanne Welsh, Christine Parkinson, Leila Khoja, Luiza Moore, Mark Tullett et al. · 2020 · Nature Communications
  62. Determination of complete chromosomal haplotypes by bulk DNA sequencing
    Richard W. Tourdot, Gregory J. Brunette, Ricardo A. Pinto, Cheng‐Zhong Zhang · 2021 · Genome biology
  63. Genome Instability in Multiple Myeloma: Facts and Factors
    Anna Yu. Aksenova, Anna S. Zhuk, Artem G. Lada, Irina V. Zotova, Elena Igorevna Stepchenkova, Ivan Ivanovich Kostroma, Sergey V. Gritsaev, Youri I. Pavlov · 2021 · Cancers
  64. Single-cell genome-wide concurrent haplotyping and copy-number profiling through genotyping-by-sequencing
    Heleen Masset, Jia Ding, Eftychia Dimitriadou, Amin Ardeshirdavani, Sophie Debrock, Olga Tšuiko, Katrien Smits, Karen Peeraer, Yves Moreau, Thierry Voet et al. · 2022 · Nucleic Acids Research
  65. Specific cell differentiation in breast cancer: a basis for histological classification
    Emad A. Rakha, Michael S. Toss, Cecily Quinn · 2021 · Journal of Clinical Pathology
  66. The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time
    Axel Rosendahl Huber, Arne van Hoeck, Ruben van Boxtel · 2021 · Frontiers in Genetics
  67. Prolonged persistence of mutagenic DNA lesions in somatic cells
    Michael Spencer Chapman, Emily Mitchell, Kenichi Yoshida, Nicholas Williams, Margarete A. Fabre, Anna Maria Ranzoni, Philip S. Robinson, Lori D. Kregar, Christian Matthias Wilk, Steffen Boettcher et al. · 2025 · Nature
  68. The evolutionary biography of chronic lymphocytic leukemia
    Xosé S. Puente, Carlos López-Otı́n · 2013 · Nature Genetics
  69. Clonal origin and spread of metastatic prostate cancer
    Jamie L. Van Etten, Scott M. Dehm · 2016 · Endocrine Related Cancer
  70. Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
    Tianqi Shi, Xiaofei Chen, Huihui Ti · 2024 · Journal of Medicinal Chemistry
  71. A survey of tandem repeat instabilities and associated gene expression changes in 35 colorectal cancers
    Tugce Bilgin Sonay, Elina Koletou, Andreas Wagner · 2015 · BMC Genomics
  72. Progenetix: 12 years of oncogenomic data curation
    Haoyang Cai, Nitin Kumar, Ni Ai, Saumya Gupta, Prisni Rath, Michael Baudis · 2013 · Nucleic Acids Research
  73. The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
    Vandana Sandhu, David C. Wedge, Inger Marie Bowitz Lothe, Knut Jørgen Labori, Stefan C. Dentro, Trond A Buanes, Martina Landschoof Skrede, Astrid Marie Dalsgaard, Else Munthe, Ola Myklebost et al. · 2016 · Cancer Research
  74. Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling
    Atsushi Niida, Satoshi Nagayama, Satoru Miyano, Koshi Mimori · 2018 · Cancer Science
  75. Genome-wide somatic mutation analysis via Hawk-Seq™ reveals mutation profiles associated with chemical mutagens
    Shoji Matsumura, Hirayuki Sato, Yuki Otsubo, Junichi Tasaki, Naohiro Ikeda, Osamu Morita · 2019 · Archives of Toxicology
  76. The genomic and epigenomic evolutionary history of papillary renal cell carcinomas
    Bin Zhu, Maria Luana Poeta, Manuela Costantini, Tongwu Zhang, Jianxin Shi, Steno Sentinelli, Zhao Wei, Vincenzo Pompeo, Maurizio Cardelli, Boian S. Alexandrov et al. · 2020 · Nature Communications
  77. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead
    Milaid Granadillo Rodríguez, Ben Flath, Linda Chelico · 2020 · Open Biology
  78. DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution
    Gryte Satas, Simone Zaccaria, Mohammed El-Kebir, Benjamin J. Raphael · 2021 · Cell Systems
  79. ReMixT: clone-specific genomic structure estimation in cancer
    Andrew McPherson, Andrew J. L. Roth, Gavin Ha, Cédric Chauve, Adi Steif, Camila P. E. de Souza, Peter D. Eirew, Alexandre Bouchard‐Côté, Samuel A. J. R. Aparicio, S. Cenk Şahinalp et al. · 2017 · Genome biology
  80. Karyotypic Aberrations in Oncogenesis and Cancer Therapy
    Vitale, Ilio, Manic, Gwenola, Senovilla, Laura, Kroemer, Guido, Galluzzi, Lorenzo · 2015 · Trends in Cancer
  81. Comprehensive genomic characterization of early-stage bladder cancer
    Frederik Prip, Philippe Lamy, Sia V. Lindskrog, Trine Strandgaard, Iver Nordentoft, Karin Birkenkamp‐Demtröder, Nicolai J. Birkbak, Nanna Kristjánsdóttir, Asbjørn Kjær, Tine G. Andreasen et al. · 2025 · Nature Genetics
  82. Cancer cells and adaptive explanations
    Pierre‐Luc Germain · 2012 · Biology & Philosophy
  83. Persistent damaged bases in DNA allow mutagenic break repair in Escherichia coli
    Jessica M. Moore, Raul Correa, Susan M. Rosenberg, P. J. Hastings · 2017 · PLoS Genetics
  84. Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures
    John F. Graf, Maria I. Zavodszky · 2017 · PLoS ONE
  85. Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
    G. Steven Bova, Heini M. L. Kallio, Matti Annala, Kati K. Kivinummi, Gunilla Högnäs, Sergei Häyrynen, Tommi Rantapero, Virpi Kivinen, William B. Isaacs, Teemu T. Tolonen et al. · 2016 · Molecular Case Studies
  86. Quantification of subclonal selection in cancer from bulk sequencing data
    Marc J. Williams, Benjamin Werner, Christina N. Curtis, Chris P. Barnes, Andrea Sottoriva, Trevor A. Graham · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Next-Generation Sequencing of Disseminated Tumor Cells
    Elen K. Møller, Parveen Kumar, Thierry Voet, April L. Peterson, Peter Van Loo, Randi R. Mathiesen, Renathe Fjelldal, Jason Grundstad, Elin Borgen, Lars Oliver Baumbusch et al. · 2013 · Frontiers in Oncology
  88. Recent advances in breast cancer research impacting clinical diagnostic practice
    Amy E. McCart Reed, Priyakshi Kalita‐de Croft, Jamie R. Kutasovic, Jodi M. Saunus, Sunil R. Lakhani · 2018 · The Journal of Pathology
  89. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
    François Bertucci, Charlotte Rypens, Pascal Finetti, Arnaud Guillé, José Adélaı̈de, Audrey Monneur, Nadine Carbuccia, Sèverine Garnier, Piet R. Dirix, Anthony Gonçalvès et al. · 2019 · Molecular Oncology
  90. Genetics and Genomics of Breast Cancer: update and translational perspectives
    Michela Biancolella, Barbara Testa, Leila Baghernajad Salehi, Maria Rosaria D’Apice, Giuseppe Novelli · 2020 · Seminars in Cancer Biology
  91. Drivers underpinning the malignant transformation of giant cell tumour of bone
    Matthew W. Fittall, Iben Lyskjær, Peter Ellery, Patrick Lombard, Jannat Ijaz, Anna‐Christina Strobl, Dahmane Oukrif, Maxime Tarabichi, Martin Sill, Christian Koelsche et al. · 2020 · The Journal of Pathology
  92. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis
    Rafat Chowdhury, Balaji Ganeshan, Sheeba Irshad, Katherine Lawler, Michel Eisenblätter, Hanna Milewicz, Manuel Rodriguez‐Justo, Kenneth Alan Miles, PA Ellis, Ashley M. Groves et al. · 2014 · British Journal of Radiology
  93. Genomic sequencing in cancer
    Musaffe Tuna, Christopher Ian Amos · 2012 · Cancer Letters
  94. Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy
    Tim H. H. Coorens, Grace Collord, Taryn D. Treger, Stuart Paul Adams, Emily Mitchell, Barbara Newman, Gad A. Getz, Anna L. Godfrey, Jack Luke Bartram, Sam Behjati · 2023 · Nature Cancer
  95. The complexity of tobacco smoke-induced mutagenesis in head and neck cancer
    Laura Torrens, Sarah Moody, Ana Carolina de Carvalho, Mariya Kazachkova, Behnoush Abedi‐Ardekani, Saamin Cheema, Sergey Senkin, Thomas Cattiaux, Ricardo Cortez Cardoso Penha, Joshua Ronald Atkins et al. · 2025 · Nature Genetics
  96. Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma
    Yi Huang, Shengjie Gao, Song Wu, Pengfei Song, Xiaojuan Sun, Xueda Hu, Shiqiang Zhang, Yuan Yu, Jialou Zhu, Cailing Li et al. · 2013 · International Journal of Cancer
  97. Translating Genomics to the Clinic: Implications of Cancer Heterogeneity
    Nardin Samuel, Thomas J. Hudson · 2012 · Clinical Chemistry
  98. Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance
    Luís Manso, Silvana Andrea Mouron, Michael L. Tress, Gonzalo Goméz-López, Manuel M. Morente, Eva Ciruelos, Miriam Rubio-Camarillo, José Luis Rodríguez‐­Peralto, Miguel Ángel Pujana, David G. Pisano et al. · 2016 · PLoS ONE
  99. Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia
    Ferran Nadeu, Ander Díaz‐Navarro, Julio Delgado, Xosé S. Puente, Elı́as Campo · 2020 · Annual Review of Pathology Mechanisms of Disease
  100. Reliable Analysis of Clinical Tumor-Only Whole-Exome Sequencing Data
    Sehyun Oh, Ludwig Geistlinger, Marcel Ramos, Martin T. Morgan, Levi Waldron, Markus Riester · 2020 · JCO Clinical Cancer Informatics